BASIC RES CARDIOL 润色咨询

BASIC RESEARCH IN CARDIOLOGY

出版年份：1973 年文章数：568 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：13.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2018-11-13 ms1700929302443684

    非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2018-06-25 家有可乐

    审稿速度:1.0
    经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2018-05-15 Johnny_sun

    最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2016-10-20 qqd140d1b8

    同问qqd140d1b8 2016-10-08 发表::
    要临床研究吗？

    qqd140d1b8 2016-10-08 发表:: 要临床研究吗？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2016-10-08 qqd140d1b8

    要临床研究吗？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2016-05-14 arlian1977

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：审稿挺快，可以一试

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2015-10-17 ruipinsu

    真的比cardiovascular res好发吗？没觉得啊

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2015-09-19 ohayonana

    审稿速度:1.0
    经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2015-07-28 223.104.11.236

    杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=848174, encodeId=cd948481e425, content=非常好的一个期刊，我们老板去年发了一篇，叫我今年再投。。感觉今年就悬了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Tue Nov 13 16:11:37 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558283, encodeId=fe4d55828379, content=审稿速度:1.0<br>经验分享：投了一篇，审稿14天，只有一个审稿人，感觉并不是很难。这个杂志一年发表文章60篇左右，除了文章质量外，还需要点运气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af941919218, createdName=家有可乐, createdTime=Mon Jun 25 16:27:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556075, encodeId=3e9a5560e5c8, content=最近这里的评论好少啊.目前有意投这个杂志.不知道 现在好投不?有转基因动物., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/15/975d4c456916ee72507306ef43a34aea.jpg, createdBy=e7852109109, createdName=Johnny_sun, createdTime=Tue May 15 00:00:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528456, encodeId=a009528456e5, content=同问<span class="quote">qqd140d1b8 2016-10-08 发表::<br>要临床研究吗？</span>, beContent=qqd140d1b8 2016-10-08 发表:: 要临床研究吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:16:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527994, encodeId=a54a52e9940e, content=要临床研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 08 14:11:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522367, encodeId=cd6752236e4a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：审稿挺快，可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat May 14 05:05:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516067, encodeId=209051606ee4, content=真的比cardiovascular res好发吗？没觉得啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 18:38:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515449, encodeId=ee5851544915, content=审稿速度:1.0<br>经验分享：投稿后三周被reject，选了两个reviewer，提了一堆意见，主要还是novelty问题。硬伤啊硬伤。不过审稿也还算快，提的意见也比较中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dbf91820, createdName=ohayonana, createdTime=Sat Sep 19 21:45:00 CST 2015, time=2015-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513953, encodeId=e5dc513953ec, content=杂志比较难投，水平较高，和cardiovascular res相当但是感觉上来说比cvr稍微好发一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.11.236, createdTime=Tue Jul 28 01:08:00 CST 2015, time=2015-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506452, encodeId=f0d8506452b2, content=《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c47111065, createdName=bubu509, createdTime=Tue Sep 30 10:17:00 CST 2014, time=2014-09-30, status=1, ipAttribution=)]
    2014-09-30 bubu509

    《心脏病学基础研究》为双月刊，出版国为德国，刊载心脏与循环系统的生理、病理、药理、生化和实验医学等基础问题的研究论文和病例报告，并不定期出版专题增刊。印刷版订户目前可免费上网。(文种：英文)

    0

共25条页码: 2/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分